why choose us

Clinical Trials Search

Showing 14,070 of 132,963 result(s)
Evaluating a Noise Reduction Algorithm With Cochlear Implant Users

Status: Completed

Condition: Hearing Impairment

Interventions: Speech Enhancement using Dynamic thresholding Approach (SEDA) is a software algorithm that removes background noise.

Date: 2023-03-23

Testing Promising Behavioral Economic Interventions to Promote Enrollment Diversity in Cardiovascular Cohort Studies

Status: Completed

Condition: Cardiovascular Diseases

Interventions: Behavioral Intervention studied here is the method of contact (text vs. email vs. email+text).

Date: 2023-03-23

Butterfly - Clinical Performance Study

Status: COMPLETED

Condition: COVID-19

Interventions: A reverse transcription, real-time polymerase chain reaction (RT-qPCR) test for the qualitative detection of SARS-CoV-2.

Date: 2023-03-23

Two Way Crossover Closed Loop MPC vs Control IQ

Status: Completed

Condition: Type 1 Diabetes

Interventions: The Model Predictive Control (MPC) insulin infusion algorithm contains a model within the controller that takes as an input the aerobic metabolic expe

Date: 2023-03-23

A First-In-Human Trial of pTTL in Advanced Colorectal Cancer

Status: Completed

Condition: Colorectal Cancer

Interventions: pTTL is an autologous cell product for adoptive cancer immunotherapy containing in vitro expanded T cells stimulated with patient-specific tumour neoa

Date: 2023-03-23

Safety Assessment of Central Medial Thalamus Stimulation Using Transcranial Focused Ultrasound

Status: Completed

Condition: Healthy

Interventions: Using MRI-guided targeting, we will administer focused ultrasound in one of the 4 stimulation conditions

Date: 2023-03-23

Increasing Adherence to Lung Cancer Screening

Status: Completed

Condition: Lung Cancer

Interventions: Brief persuasive messaging to increase awareness about the importance of annual lung cancer screening and completion of recommended follow-up sent to

Date: 2023-03-23

Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.

Status: COMPLETED

Condition: Plaque Psoriasis

Interventions: Injection Secukinumab 150mg subcutaneously will be administered at weeks 0, 1, 2, 3, 4, and then monthly for 5 months.

Date: 2023-03-22

Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults

Status: Completed

Condition: Tuberculosis

Interventions: Cohort 1: 50 mg Cohort 2: 150 mg Cohort 3: 300 mg Cohort 4: 600 mg Cohort 5: TBD Cohort 6: TBD

Date: 2023-03-22